Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable (I)-42 (IGLVI-42) is a **human pseudogene** located within the lambda light chain variable region locus of immunoglobulin genes[2][3][5]. Immunoglobulin variable region genes are critical for generating antibody diversity; however, pseudogenes like IGLVI-42 contain genetic alterations (such as frameshift mutations or premature stop codons) that render them nonfunctional, meaning they do not encode a protein product and do not contribute directly to immunity or pathology[3][4]. There is no evidence for expression, functional involvement, disease association, or therapeutic targeting for IGLVI-42. Its identification is used primarily in genomics and immunogenetics to annotate the full repertoire of immunoglobulin gene segments.\n\n*Note: If you are searching for an active immunoglobulin lambda variable region involved in disease, immunity, or serving as a drug target, you should specify a functional member of the IGLV gene family, not a pseudogene.*
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable (I)-42 (pseudogene) (IGLVI-42).